Table 1 Patient baseline characteristics and disease severity markers for patients receiving DrotAA
Variable | Canadian sites (n = 305) |
|---|---|
Gender, % male | 57.7 |
Mean age, years (SD) | 56.9 (17.2) |
Mean APACHE II (SD) | 25.3 (7.8) |
Mean number of organ dysfunctions (SD) | 3.1 (1.2) |
Mean SOFA score (SD) | 10.9 (3.6) |
Vasopressor use | 81.6% |
Mechanical ventilation | 90.5% |